These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 28481195)

  • 1. Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging.
    Kühn JP; Meffert P; Heske C; Kromrey ML; Schmidt CO; Mensel B; Völzke H; Lerch MM; Hernando D; Mayerle J; Reeder SB
    Radiology; 2017 Sep; 284(3):706-716. PubMed ID: 28481195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Automated Whole-Liver MRI Segmentation to Assess Steatosis and Iron Quantification in Chronic Liver Disease.
    Martí-Aguado D; Jiménez-Pastor A; Alberich-Bayarri Á; Rodríguez-Ortega A; Alfaro-Cervello C; Mestre-Alagarda C; Bauza M; Gallén-Peris A; Valero-Pérez E; Ballester MP; Gimeno-Torres M; Pérez-Girbés A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Escudero-García D; Serra MA; Martí-Bonmatí L
    Radiology; 2022 Feb; 302(2):345-354. PubMed ID: 34783592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of liver fat in the presence of iron overload.
    Horng DE; Hernando D; Reeder SB
    J Magn Reson Imaging; 2017 Feb; 45(2):428-439. PubMed ID: 27405703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis.
    Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB
    J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate simultaneous quantification of liver steatosis and iron overload in diffuse liver diseases with MRI.
    França M; Alberich-Bayarri Á; Martí-Bonmatí L; Oliveira P; Costa FE; Porto G; Vizcaíno JR; Gonzalez JS; Ribeiro E; Oliveira J; Pessegueiro Miranda H
    Abdom Radiol (NY); 2017 May; 42(5):1434-1443. PubMed ID: 28110367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Feasibility of Magnetic Resonance Imaging for Quantification of Liver, Pancreas, Spleen, Vertebral Bone Marrow, and Renal Cortex R2* and Proton Density Fat Fraction in Transfusion-Related Iron Overload.
    İdilman İS; Gümrük F; Haliloğlu M; Karçaaltıncaba M
    Turk J Haematol; 2016 Mar; 33(1):21-7. PubMed ID: 26376710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study.
    Rostoker G; Loridon C; Griuncelli M; Rabaté C; Lepeytre F; Ureña-Torres P; Issad B; Ghali N; Cohen Y
    EBioMedicine; 2019 Jan; 39():461-471. PubMed ID: 30502056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized Approach for ROI-Based Measurements of Proton Density Fat Fraction and R2* in the Liver.
    Campo CA; Hernando D; Schubert T; Bookwalter CA; Pay AJV; Reeder SB
    AJR Am J Roentgenol; 2017 Sep; 209(3):592-603. PubMed ID: 28705058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deep Learning for Inference of Hepatic Proton Density Fat Fraction From T1-Weighted In-Phase and Opposed-Phase MRI: Retrospective Analysis of Population-Based Trial Data.
    Wang K; Cunha GM; Hasenstab K; Henderson WC; Middleton MS; Cole SA; Umans JG; Ali T; Hsiao A; Sirlin CB
    AJR Am J Roentgenol; 2023 Nov; 221(5):620-631. PubMed ID: 37466189
    [No Abstract]   [Full Text] [Related]  

  • 10. Liver R2* is affected by both iron and fat: A dual biopsy-validated study of chronic liver disease.
    Karlsson M; Ekstedt M; Dahlström N; Forsgren MF; Ignatova S; Norén B; Dahlqvist Leinhard O; Kechagias S; Lundberg P
    J Magn Reson Imaging; 2019 Jul; 50(1):325-333. PubMed ID: 30637926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental quantification of hepatic lipid content based on volumetric MRI data in patients with suspected iron overload.
    Wunderlich AP; Cario H; Kannengießer S; Grunau V; Götz M; Hüttner F; Backhus J; Beer M; Schmidt SA
    Rofo; 2024 May; 196(5):463-470. PubMed ID: 38081191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease.
    Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB;
    J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software.
    Orcel T; Chau HT; Turlin B; Chaigneau J; Bannier E; Otal P; Frampas E; Leguen A; Boulic A; Saint-Jalmes H; Aubé C; Boursier J; Bardou-Jacquet E; Gandon Y
    Eur Radiol; 2023 Dec; 33(12):8999-9009. PubMed ID: 37402003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of the magnetic resonance 3D multiecho Dixon sequence for quantifying hepatic iron overload and steatosis in patients with thalassemia.
    Zhao F; Chen Y; Zhou T; Tang C; Huang J; Zhang H; Kannengiesser S; Long L
    Magn Reson Imaging; 2024 Sep; 111():28-34. PubMed ID: 38492786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hepatic steatosis and iron content at 3 Tesla: comparison of two-point Dixon, quantitative multi-echo Dixon, and MR spectroscopy.
    Zhan C; Olsen S; Zhang HC; Kannengiesser S; Chandarana H; Shanbhogue KP
    Abdom Radiol (NY); 2019 Sep; 44(9):3040-3048. PubMed ID: 31286208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interexamination repeatability and spatial heterogeneity of liver iron and fat quantification using MRI-based multistep adaptive fitting algorithm.
    Sofue K; Mileto A; Dale BM; Zhong X; Bashir MR
    J Magn Reson Imaging; 2015 Nov; 42(5):1281-90. PubMed ID: 25920074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intra-examination agreement between multi-echo gradient echo and confounder-corrected chemical shift-encoded MR sequences for R2* estimation as a biomarker of liver iron content in patients with a wide range of T2*/R2* and proton density fat fraction values.
    Moura Cunha G; Kolokythas O; Chen W; Akcicek H; Hitt D; Briller NE; Amin K
    Abdom Radiol (NY); 2023 Jul; 48(7):2302-2310. PubMed ID: 37055586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous quantification of hepatic MRI-PDFF and R2* in a rabbit model with nonalcoholic fatty liver disease.
    Wang X; Zhang X; Ma L; Li S
    Sci China Life Sci; 2018 Sep; 61(9):1107-1114. PubMed ID: 29934919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease by Using Quantitative US.
    Han A; Zhang YN; Boehringer AS; Montes V; Andre MP; Erdman JW; Loomba R; Valasek MA; Sirlin CB; O'Brien WD
    Radiology; 2020 Apr; 295(1):106-113. PubMed ID: 32013792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of a Low-Rank Denoising Algorithm on Quantitative Magnetic Resonance Imaging-Based Measures of Liver Fat and Iron.
    Allen BC; Lugauer F; Nickel D; Bhatti L; Dafalla RA; Dale BM; Jaffe TA; Bashir MR
    J Comput Assist Tomogr; 2017; 41(3):412-416. PubMed ID: 28505623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.